SCOTT GREENWOOD: Open Payments
NPI 1699091728 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 69 payments from 16 companies in 2025. Trend: 2023 $1,280 · 2024 $1,200 · 2025 $1,334
Food & beverage: $1,334
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $212 |
| GlaxoSmithKline, LLC. | 7 | $165 |
| Lilly USA, LLC | 8 | $137 |
| Exact Sciences Corporation | 7 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Astellas Pharma US Inc | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| SHIELD THERAPEUTICS INC | 1 | $74 |
| Avvisto Therapeutics, LLC | 3 | $55 |
Products named: JARDIANCE, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Kerendia, Veozah, ACCRUFER, AIRSUPRA, CYCLOSET.
Industry payments across TX — which companies pay providers there.
